Orion Portfolio Solutions LLC raised its position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 4.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 155,390 shares of the company's stock after purchasing an additional 6,934 shares during the quarter. Orion Portfolio Solutions LLC's holdings in Procter & Gamble were worth $26,051,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of PG. NewSquare Capital LLC grew its position in shares of Procter & Gamble by 933.3% during the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock worth $26,000 after buying an additional 140 shares during the period. RPg Family Wealth Advisory LLC acquired a new stake in Procter & Gamble in the third quarter worth $33,000. LFA Lugano Financial Advisors SA bought a new stake in Procter & Gamble in the fourth quarter valued at $34,000. Atlantic Private Wealth LLC raised its holdings in shares of Procter & Gamble by 95.3% during the fourth quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock valued at $35,000 after purchasing an additional 101 shares during the period. Finally, Noble Wealth Management PBC bought a new position in shares of Procter & Gamble during the 4th quarter worth about $39,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Performance
NYSE PG traded up $1.58 on Monday, hitting $169.61. 2,938,337 shares of the stock traded hands, compared to its average volume of 7,659,134. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The business's fifty day moving average is $168.60 and its two-hundred day moving average is $169.31. The Procter & Gamble Company has a 12 month low of $153.52 and a 12 month high of $180.43. The firm has a market capitalization of $397.70 billion, a price-to-earnings ratio of 27.00, a PEG ratio of 3.76 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. The company had revenue of $21.88 billion during the quarter, compared to analyst estimates of $21.66 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The firm's revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.84 EPS. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Investors of record on Friday, January 24th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. Procter & Gamble's dividend payout ratio is 64.01%.
Analyst Ratings Changes
A number of research analysts recently weighed in on the company. UBS Group reaffirmed a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Piper Sandler lowered their target price on Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating on the stock in a research report on Monday, February 24th. Royal Bank of Canada reissued a "sector perform" rating and issued a $164.00 price target on shares of Procter & Gamble in a research report on Thursday, January 23rd. Barclays restated an "equal weight" rating on shares of Procter & Gamble in a report on Thursday. Finally, Wells Fargo & Company lifted their price objective on shares of Procter & Gamble from $176.00 to $180.00 and gave the company an "overweight" rating in a report on Thursday, January 23rd. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and three have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $181.82.
Check Out Our Latest Report on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the sale, the insider now directly owns 172,814 shares in the company, valued at $28,313,845.76. This represents a 34.36 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary A. Coombe sold 35,000 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $173.68, for a total value of $6,078,800.00. Following the completion of the sale, the chief executive officer now owns 22,051 shares in the company, valued at $3,829,817.68. This trade represents a 61.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 143,450 shares of company stock valued at $23,988,008 in the last 90 days. 0.18% of the stock is currently owned by company insiders.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.